Aheim-managed funds sold Remy & Geiser, a leading pharmaceutical packaging supplier in Western Europe, to a family office for strategic alignment and growth opportunities.

Target Information

In 2008, the funds advised by Aheim, along with Christoph Hanschke as the new managing director, acquired 100% of the shares of Remy & Geiser as part of a succession plan. Remy & Geiser is recognized as one of the leading suppliers of primary packaging for the pharmaceutical industry in Western Europe. With over a century of tradition, the company employed approximately 250 staff members at its headquarters in Westerwald and at its two production sites in Thuringia at the time of the acquisition.

Following the acquisition, the Aheim funds launched an extensive investment program amounting to several million euros. This initiative focused on strengthening the second level of management, creating new jobs, and enhancing the company's capacity and efficiency through targeted process optimizations.

Industry Overview

The pharmaceutical packaging industry in Germany is characterized by innovation and rigorous compliance with regulatory standards. As a central player in the EU market, Germany's pharmaceutical sector relies heavily on reliable packaging solutions